The BIO International Convention remains one of the leading global forums for biotechnology, pharmaceutical, and life sciences innovation. The conference brings together executives, investors, scientists, and strategic partners focused on advancing therapies, scaling platforms, and structuring complex collaborations across the industry.

LexStrat Law will attend BIO International Convention 2026 in San Diego, CA (June 22nd - 25th) to engage directly with founders, operators, and investors navigating the legal and strategic dimensions of growth in regulated markets.

Innovation in life sciences increasingly requires alignment across science, capital, regulatory pathways, manufacturing strategy, data infrastructure, and commercial execution. Strategic transactions, licensing arrangements, co-development structures, and supply chain partnerships must be designed not only to close, but to function under real-world regulatory and operational pressures.

LexStrat works alongside life sciences and pharmaceutical companies at critical inflection points, including formation and early financing, platform expansion, clinical and commercial partnering, cross-border transactions, and complex procurement and vendor ecosystems. Our focus is practical and execution-oriented, informed by direct experience inside large enterprises and innovation-driven environments.

Participation in BIO allows LexStrat to remain closely connected to market dynamics, evolving deal structures, and the operational realities shaping the sector. We remain committed to helping clients accelerate growth while building durable legal and strategic frameworks designed to endure in highly regulated industries.